Astellas Pharma s.r.o. is the Czech subsidiary of Astellas, a global pharmaceutical company focused on research-driven innovative therapies. The Prague-based affiliate manages commercial, medical, regulatory and support operations for the Czech Republic and typically also provides coordination for Slovakia. The company's therapeutic focus reflects the global Astellas portfolio, covering oncology, urology, transplant medicine, immunology, nephrology and other areas of high medical need. In the Czech Republic, it maintains established positions mainly in urology, transplantation and dermatology and supports the introduction of new targeted therapies in oncology. The affiliate also contributes to clinical research activities, medical education, pharmacovigilance and compliance programmes aligned with global standards. Astellas Pharma s.r.o. positions itself as a provider of innovative, evidence-based therapies with a strategic emphasis on patient benefit, ethical operations and long-term collaboration with healthcare institutions and professionals.
Headquarters
Rohanske nabrezi 678/29
Prague; The City of Prague;
Postal Code: 18600
Contact Details: Purchase the Astellas Pharma S.R.O. report to view the information.
Website: https://www.astellas.com/cz
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service